Ximelagatran: Direct Thrombin Inhibitor

por Ho, Shir-Jing, Brighton, Tim A
Publicado 2006

Crystalglobulinemia in Multiple Myeloma: A Rare Case Report of Survival and Renal Recovery

por Chou, Angela, Long, Christopher, Vonthethoff, Leon, Ho, Shir-Jing, Pettit, Franziska, Badve, Sunil V.
Publicado 2020

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma

por Tatarczuch, Maciej, Waltham, Mark, Shortt, Jake, Polekhina, Galina, Hawkes, Eliza A., Ho, Shir-Jing, Trotman, Judith, Brasacchio, Daniella, Co, Melannie, Li, Jessica, Ramakrishnan, Vanitha, Dunne, Karin, Opat, Stephen S., Gregory, Gareth P.
Publicado 2023

Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma

por Nath, Christa Ellen, Grigg, Andrew, Rosser, Sebastian P. A., Estell, Jane, Newman, Elizabeth, Tiley, Campbell, Ramanathan, Sundra, Ho, Shir Jing, Larsen, Stephen, Gibson, John, Presgrave, Peter, Shaw, Peter John, Trotman, Judith
Publicado 2022

Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14)

por Bahlis, Nizar J., Baz, Rachid, Harrison, Simon J., Quach, Hang, Ho, Shir-Jing, Vangsted, Annette Juul, Plesner, Torben, Moreau, Philippe, Gibbs, Simon D., Coppola, Sheryl, Yang, Xiaoqing, Al Masud, Abdullah, Ross, Jeremy A., Bueno, Orlando, Kaufman, Jonathan L.
Publicado 2021

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study

por Opat, Stephen, Tedeschi, Alessandra, Hu, Bei, Linton, Kim M., McKay, Pamela, Leitch, Sophie, Coleman, Morton, Zinzani, Pier Luigi, Jin, Jie, Sun, Mingyuan, Sobieraj-Teague, Magdalena, Browett, Peter, Ke, Xiaoyan, Thieblemont, Catherine, Ardeshna, Kirit, Bijou, Fontanet, Walker, Patricia, Hawkes, Eliza A., Ho, Shir-Jing, Zhou, Keshu, Liang, Zhiyu, Xu, Jianfeng, Tankersley, Chris, Delarue, Richard, Co, Melannie, Trotman, Judith
Publicado 2023

Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 12...

por Favaloro, Emmanuel J., Clifford, Joanne, Leitinger, Emma, Parker, Michael, Sung, Pauline, Chunilal, Sanjeev, Tran, Huyen, Kershaw, Geoffrey, Fu, Suki, Passam, Freda, Ahuja, Monica, Ho, Shir Jing, Duncan, Elizabeth, Yacoub, Olivia, Tan, Chee Wee, Kaminskis, Lisa, Modica, Natasha, Pepperell, Dominic, Ballard, Leanne, Clarke, Lisa, Lee, Christine S.M., Gardiner, Elizabeth E., Young‐Ill Choi, Philip, Tohidi‐Esfahani, Ibrahim, Bird, Robert, Brighton, Timothy, Chen, Vivien M.
Publicado 2022

The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma

por Opat, Stephen, Tedeschi, Alessandra, Linton, Kim, McKay, Pamela, Hu, Bei, Chan, Henry, Jin, Jie, Sobieraj-Teague, Magdalena, Zinzani, Pier Luigi, Coleman, Morton, Thieblemont, Catherine, Browett, Peter, Ke, Xiaoyan, Sun, Mingyuan, Marcus, Robert, Portell, Craig A., Ardeshna, Kirit, Bijou, Fontanet, Walker, Patricia, Hawkes, Eliza A., Mapp, Sally, Ho, Shir-Jing, Talaulikar, Dipti, Zhou, Ke-Shu, Co, Melannie, Li, Xiaotong, Zhou, Wenxiao, Cappellini, Massimo, Tankersley, Chris, Huang, Jane, Trotman, Judith
Publicado 2021